Tag Archive for: POC study

Patients with emerging sepsis can be stratified on the basis of blood concentrations of bio-ADM. © Spingotec GmbH

German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.